Adam Durbin: Scientists, Clinicians, and Advocates Unite to Advance Neuroblastoma Research
Adam Durbin, Assistant Member at St. Jude Children’s Research Hospital, shared on LinkedIn: “An incredible honor to be a part of the NDDS4/LifeArc meeting in Utrecht, at the beautiful Princess […]
Read the full articleYou might also wanna read
Targeting RBM5 may help disrupt 'undruggable' MYC in childhood leukemia
Scientists from St. Jude Children's Research Hospital and collaborators have identified the RNA-binding protein RBM5 as a potential vulnerab
Bipartisan bill seeks to bolster AI use in pediatric cancer care
Members of the Childhood Cancer Caucus are proposing the Accelerating Innovation for Kids Act, aimed at fast-tracking the deployment of this
How Udall Centers Support PD Research
Dr. Sophie Cho, Program Director in the Division of Clinical Research at NINDS, discusses the state of Parkinson disease research. \
Targeting Mutant Isocitrate Dehydrogenase Acute Myeloid Leukemias by Leveraging Fructose
Briana Turner Biochemistry and Structural Biology Chairperson: Dr. John Blenis Major Sponsors: Dr. Kayvna Keshari and Dr. Michael Kharas Min
AI-guided discovery identifies GPNMB as promising CAR T cell target for multiple cancers
An AI-guided framework integrating high-resolution cellular atlases, public knowledge databases, and large language models enables a modular
Long-term outcomes for childhood cancer; new autoimmune research center; skull-base surgery: Upstate Medical University's HealthLink on Air for Sunday, Aug. 27, 2017
Pediatrician Pediatrician Amy Caruso Brown, MD Amy Caruso Brown, MD , discusses long-range outcomes in pediatric cancer. Rheumatology chief,
Comments
Sign in to join the conversation.
No comments yet. Be the first.